• Complex
  • Title
  • Author
  • Keyword
  • Abstract
  • Scholars
Search

Author:

Wang, Li-Ping (Wang, Li-Ping.) | Wang, Yan (Wang, Yan.) | Zhao, Li-Mei (Zhao, Li-Mei.) | Li, Gui-Rong (Li, Gui-Rong.) | Deng, Xiu-Ling (Deng, Xiu-Ling.)

Indexed by:

SCIE PubMed Scopus

Abstract:

The proliferation of cardiac fibroblasts is implicated in the pathogenesis of myocardial remodeling and fibrosis. Intermediate-conductance calcium-activated K+ channels (K(Ca)3.1 channels) have important roles in cell proliferation. However, it is unknown whether angiotensin II (Ang II), a potent profibrotic molecule, would regulate K(Ca)3.1 channels in cardiac fibroblasts and participate in cell proliferation. In the present study, we investigated whether K(Ca)3.1 channels were regulated by Ang II, and how the channel activity mediated cell proliferation in cultured adult rat cardiac fibroblasts using electrophysiology and biochemical approaches. It was found that mRNA, protein, and current density of K(Ca)3.1 channels were greatly enhanced in cultured cardiac fibroblasts treated with 1 mu M Ang II, and the effects were countered by the angiotensin type 1 receptor (AT(1)R) blocker losartan, the p38-MAPK inhibitor SB203580, the ERK1/2 inhibitor PD98059, and the PI3K/Akt inhibitor LY294002. Ang II stimulated cell proliferation and the effect was antagonized by the K(Ca)3.1 blocker TRAM-34 and siRNA targeting K(Ca)3.1. In addition, Ang II-induced increase of K(Ca)3.1 expression was attenuated by transfection of activator protein-1 (AP-1) decoy oligodeoxynucleotides. These results demonstrate for the first time that Ang II stimulates cell proliferation mediated by upregulating K(Ca)3.1 channels via interacting with the AT(1)R and activating AP-1 complex through ERK1/2, p38-MAPK and PI3K/Akt signaling pathways in cultured adult rat cardiac fibroblasts. (c) Crown Copyright 2013 Published by Elsevier Inc. All rights reserved.

Keyword:

Angiotensin II Cardiac fibroblasts Intermediate-conductance Ca2+ activated K+ channels Proliferation

Author Community:

  • [ 1 ] [Wang, Li-Ping; Wang, Yan; Zhao, Li-Mei; Deng, Xiu-Ling] Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, Xian 710061, Shaanxi, Peoples R China
  • [ 2 ] [Wang, Yan; Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China
  • [ 3 ] [Wang, Yan; Li, Gui-Rong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Physiol, Pokfulam, Hong Kong, Peoples R China
  • [ 4 ] [Deng, Xiu-Ling] Xi An Jiao Tong Univ, Sch Med, Cardiovasc Res Ctr, Xian 710061, Shaanxi, Peoples R China

Reprint Author's Address:

  • Xi An Jiao Tong Univ, Sch Med, Dept Physiol & Pathophysiol, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.

Show more details

Related Keywords:

Source :

BIOCHEMICAL PHARMACOLOGY

ISSN: 0006-2952

Year: 2013

Issue: 10

Volume: 85

Page: 1486-1494

4 . 6 5

JCR@2013

5 . 8 5 8

JCR@2020

ESI Discipline: PHARMACOLOGY & TOXICOLOGY;

ESI HC Threshold:179

JCR Journal Grade:2

CAS Journal Grade:2

Cited Count:

WoS CC Cited Count: 35

SCOPUS Cited Count: 44

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 7

Affiliated Colleges:

FAQ| About| Online/Total:1423/173341865
Address:XI'AN JIAOTONG UNIVERSITY LIBRARY(No.28, Xianning West Road, Xi'an, Shaanxi Post Code:710049) Contact Us:029-82667865
Copyright:XI'AN JIAOTONG UNIVERSITY LIBRARY Technical Support:Beijing Aegean Software Co., Ltd.